Investigating cardiovascular disease risk factors in elderly diabetic patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort study aims to explore the prevalence, management, and nutritional status of elderly patients aged 65 and older with diabetes in Shanghai and Suzhou. Over a period of ten years, the study will enroll 5,000 participants and collect baseline information, with follow-ups every two years. The primary outcomes will include major adverse cardiovascular events, all-cause mortality, and chronic complications related to diabetes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Men or women aged 65-100 years old;
* Patients who had been diagnosed with diabetes mellitus.

Exclusion Criteria:

* Patients with psychiatric disorders or impaired cognitive function;
* Patients who cannot or reject to sign the consent form.

Where it's running

• Xuejian Ni
  Suzhou, Jiangsu, China Recruiting

Study contacts

• Principal investigator: Xiaoying Li, MD — Fudan University
• Study coordinator: Xiaomu Li, MD
• Email: li.xiaomu@zs-hospital.sh.cn
• Phone: 13661676591

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Home-based cardiovascular health screening for people turning 50, 55, 60, 65, 70 or 75 in Uppsala

  This trial tests whether giving people a home blood pressure monitor, a dried blood spot kit, and a questionnaire can find more cardiovascular risk factors than usual care.

  Recruiting Uppsala University · Uppsala · NCT07614659

• Streamlined renal denervation with Spyral for uncontrolled high blood pressure

  This trial will test whether a shorter, simpler renal denervation procedure using the Symplicity Spyral system can lower blood pressure in adults with uncontrolled hypertension.

  Recruiting at 20 sites Medtronic Vascular · Melbourne and 20 other locations · NCT07115953

• Gemini multi-organ denervation for uncontrolled high blood pressure

  The Gemini System is being tested to see if multi-organ denervation is safe and can lower blood pressure in adults with uncontrolled hypertension, with or without high cardiovascular risk.

  Recruiting at 18 sites Medtronic Vascular · Stanford, California and 17 other locations · NCT06907147

• Evaluating human placental membrane products for treating nonhealing diabetic foot and venous leg ulcers

  This study is testing whether using human placental products along with regular care can help people with stubborn diabetic foot and leg ulcers heal better.

  Recruiting C5 Biomedical · Metairie, Louisiana · NCT06674980

• Preventing heart disease in high-risk diabetes patients

  This study is testing whether stronger medication for adults with type 2 diabetes and high heart disease risk can help prevent heart problems compared to regular treatment.

  Recruiting Phase 4 National Heart Centre Singapore · Singapore · NCT04286399

• Study on chronic kidney disease in American Indian populations

  This study looks at chronic kidney disease and heart problems in American Indians to see what makes their health different and to gather important health information for future research.

  Recruiting at 2 sites University of New Mexico · Phoenix, Arizona and 2 other locations · NCT04185844

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.